Preferential treatment of state-owned pharmaceutical firms in Thailand affecting UK exporters and investors
Trade barrier summary
Thai government procurement regulation allows price advantages for state-owned enterprises and the government pharmaceutical organisations (GPO) . Hospitals are also required to purchase medicines exclusively from the GPO. Overseas businesses do not have access to those benefits.
Sectors affected
- Pharmaceuticals and biotechnology
- Healthcare services
Resolved
No
Date reported
22 July 2019
Last updated
17 December 2020
Public ID
PID-9PJZ79
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.